Skip to content

Starfighters Space, Inc. FJET Deferred Financing Costs Recognized As Equity Issuance Costs Non Cash

Deferred Financing Costs Recognized As Equity Issuance Costs Non Cash at other companies

AMB
Ambiq Micro, Inc.AMBQ
-$75K
Regenxbio logo
RegenxbioRGNX
$124.75K-20.5%
Excelerate Energy logo
Excelerate EnergyEE
$0+100%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$0-100%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$7.5K
Teads Holding Co. Common Stock logo
Teads Holding Co. Common StockTEAD
$50K-99.8%

Other financials

Income statement

See full
Net income-$4.3M-60.9%
EPS (diluted)-$0.10+23.1%

Balance sheet

See full
Cash & equivalents$1.4M-65.0%
Total debt$477.5K
Total equity$22.4M+593%
Total assets$26.3M

Cash flow

See full
Operating cash flow-$4.0M-137%
CapEx$37.7K
Free cash flow-$2.1M-117%

Valuation

See full
Market cap$264.01M-30.2%
Enterprise value$263.09M

Returns & leverage

See full
Return on equity-203.1%
Debt / equity
Current ratio5.2×

Where this comes from

Reported directly by Starfighters Space, Inc. in its filing.

Tagged under the XBRL concept fjet:DeferredFinancingCostsRecognizedAsEquityIssuanceCostsNonCash.

The official record: Starfighters Space, Inc. ’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Starfighters Space, Inc. 's deferred financing costs recognized as equity issuance costs non cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Starfighters Space, Inc. 's deferred financing costs recognized as equity issuance costs non cash?
Starfighters Space, Inc. (FJET) reported deferred financing costs recognized as equity issuance costs non cash of $0 in Q1 2026.
What does deferred financing costs recognized as equity issuance costs non cash mean?
Represents the portion of deferred financing costs that are reclassified or recognized directly as equity issuance costs. This metric tracks the non-cash impact of capital raising efforts on shareholders' equity. It helps investors isolate the true cost of equity financing from operational expenses.